Vineet Laboratories Limited has reported significant share sales by three of its promoters, according to recent disclosures made to the stock exchanges.

Key Share Sale Details

Mrs. Gaddam Venkata Rama, a promoter of the company, sold a total of 1,10,000 equity shares in two separate transactions:

• She sold 30,000 shares for ₹9.32 lakh.
• She offloaded an additional 80,000 shares for ₹25.48 lakh.

These transactions reduced her shareholding in the company from 4.12% to 2.93%.

Mr. Alluri Prabhakar Raju, another promoter, sold 49,165 equity shares for ₹15.66 lakh. This sale decreased his stake in the company from 2.58% to 2.05%.

Additionally, Mrs. Alluri Maithili, also a promoter, sold 27,000 shares for ₹8.60 lakh, reducing her shareholding from 1.68% to 1.38%.

Transaction Details

All the transactions were executed on the National Stock Exchange (NSE) through on-market sales. The total value of shares sold by these promoters amounts to approximately ₹1.41 crore.

Transaction Summary

Regulatory Compliance

The company has made these disclosures in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The information was submitted to both the BSE and NSE.

Company Background

Vineet Laboratories Limited, with its registered office in Hyderabad, operates in the pharmaceutical sector. The company's shares are listed on both the National Stock Exchange and the Bombay Stock Exchange.

These share sales by promoters often attract investor attention as they may be perceived as a signal about the company's future prospects or the promoters' confidence in the business. However, it's important to note that promoters may sell shares for various reasons, including personal financial planning or portfolio diversification, and such transactions do not necessarily reflect on the company's performance or outlook.

Vineet Laboratories Limited , a pharmaceutical company, has reported significant changes in its promoter shareholding. According to recent disclosures, the company's promoter, Valluru Vara Prasad Rao, has reduced his stake through two separate share sale transactions on the National Stock Exchange (NSE).

First Transaction

Valluru Vara Prasad Rao sold 607 equity shares of Vineet Laboratories Limited. The transaction was valued at ₹20,237.38, resulting in a reduction of his shareholding from 17.97% to 17.37% of the company's equity.

Second Transaction

A subsequent and larger transaction took place. In this instance, the promoter sold 14,000 equity shares, with the sale amounting to ₹10,50,044. This further reduced Valluru Vara Prasad Rao's stake in the company from 17.37% to 14.15%.

Impact on Promoter Holding

The two transactions, executed through on-market sales on the NSE, have resulted in a significant decrease in the promoter's shareholding. The total reduction in Valluru Vara Prasad Rao's stake amounts to approximately 3.82 percentage points.

Regulatory Compliance

In compliance with the Securities and Exchange Board of India (SEBI) regulations, specifically the SEBI (Prohibition of Insider Trading) Regulations, 2015, Vineet Laboratories Limited has duly informed the stock exchanges about these transactions. The company's Company Secretary and Compliance Officer, Ramesh Kumar Bandari, submitted the required disclosures to both the BSE Limited and the National Stock Exchange of India Limited.

Company Details

Vineet Laboratories Limited, with the ISIN INE505Y01010, is listed on both the BSE and NSE. The company's registered office is located in Hyderabad, Telangana.

This share sale by a key promoter may be of interest to investors and market analysts tracking the pharmaceutical sector and Vineet Laboratories Limited in particular. However, it's important to note that the reasons behind the share sale have not been disclosed in the available information.